3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 3
4
Phase 2
3
Phase 1
3
Phase 2/3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
6
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Gliosarcoma
4
Nasopharyngeal Carcinoma
3
Urinary Bladder Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Glioma
2
Congenital Abnormalities
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Tongue Neoplasms
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Lung Neoplasms
1
Liver Neoplasms
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
pembrolizumab
17
Cisplatin
11
Carboplatin
9
Cyclophosphamide
8
fludarabine
6
Paclitaxel
6
Nivolumab
6
Bevacizumab
6
aldesleukin
5
Radiotherapy
5
toripalimab
4
tisotumab vedotin
4
fludarabine phosphate
4
Topotecan
4
Interleukin-2
4
Docetaxel
4
Brachytherapy
4
spartalizumab
3
Ipilimumab
3
Fulvestrant
3
ferumoxtran-10
2
enzalutamide
2
durvalumab
2
cemiplimab
2
bemarituzumab
2
balstilimab
2
Trastuzumab
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Injections
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Uterine Cervical Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT01230996
2019-04-24
DEPICT
Barts & The London NHS Trust
Phase 1/2
Completed
22 enrolled